|
|
 | | | |
- close
- close
- close
- close
QUOTE AND NEWS
Benzinga
May 1
Comment
Wunderlich Securities raises its price target from $14 to $18 on Hold-rated Conceptus (NASDAQ: CPTS) following the company's settlement of a suit with Hologic (NASDAQ: HOLX).
Wunderlich Securities comments, "On Monday, Conceptus (CPTS) and...
StreetInsider.com
Apr 30
Comment
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.
52-Week High:
Kraft Foods Inc. (NYSE: KFT) high of $39.92. Kraft Foods moved well over 1 percent on the sessoion Monday to its...
Clusterstock
Apr 30
Comment
The Dow, Nasdaq, and S&P 500 are all down, with the Nasdaq dropping 0.7%.
Here are a few stocks that are making big, big moves.
Winners:
Barnes & Noble, Inc. (BKS):
Up 61.3%
— Microsoft and Barnes & Noble have teamed up for a project...
Benzinga
Apr 30
Comment
Conceptus, Inc. (Nasdaq: CPTS) today announced that it has reached an agreement with Hologic, Inc. (Nasdaq: HOLX) to settle the ongoing patent infringement litigation related to Hologic's Adiana Permanent Contraception System. The settlement...
Benzinga
Apr 17
Comment
Piper Jaffray initiates its coverage on Conceptus (NASDAQ: CPTS) with a Neutral rating and a price target of $14 as the company has still much to prove as it transitions back to growth.
Piper Jaffray comments, "We believe the company has...
Benzinga
Apr 11
Comment
Conceptus (Nasdaq: CPTS) announced today that the U.S. Food and Drug Administration has approved inclusion of 10 years of data on Essure effectiveness in commercial settings in the Essure procedure U.S. Instructions for Use and Patient Information...
Globe Newswire
Mar 26
Comment
MOUNTAIN VIEW, Calif., March 26, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading non-surgical permanent birth control method, announced today that it has hired Lori Ciano to the newly created
Benzinga
Feb 29
Comment
Conceptus, Inc. (Nasdaq: CPTS) announced today that the U.S. Food and Drug Administration approved labeling changes pertaining to the use of bipolar radio frequency NovaSure® Impedance Controlled Endometrial Ablation System(1) following the...
Benzinga
Feb 7
Comment
Conceptus, Inc. (Nasdaq: CPTS) announced today that it intends to file an appeal to overturn the court's ruling denying Conceptus' motion for permanent injunction against Hologic Inc.'s Adiana system. In addition, Hologic has today filed an appeal...
Benzinga
Jan 9
Comment
Conceptus, Inc. (Nasdaq: CPTS) announced today that Judge William Alsup of the United States District Court, Northern District of California, denied Hologic Inc.'s motions seeking to overturn the jury's verdict that the use of Hologic's Adiana...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
